Join us for this episode with Dr. Jenn Simmons, an integrative breast surgeon and oncologist, alongside host Dr. Jaclyn Smeaton and DUTCH founder Mark Newman. This conversation deepens the discussion from a previous episode on hormones and breast cancer risk, challenging widely held clinical assumptions rooted in the Women's Health Initiative (WHI) study.
This episode also explores:
The critical distinction between progestins and progesterone
The role of metabolic dysfunction in cancer development
Breast cancer as a disease of hormone deficiency, particularly progesterone deficiency, rather than hormone excess
The impact of estrogen metabolism, especially the 4-hydroxy pathway, and how the DUTCH Test can provide insight into these pathways
Individualized hormone therapy for breast cancer survivors
Podden och tillhörande omslagsbild på den här sidan tillhör
DUTCH Test. Innehållet i podden är skapat av DUTCH Test och inte av,
eller tillsammans med, Poddtoppen.
